Stable suspension formulations of erythropoietin receptor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/10 (2006.01) A61K 38/18 (2006.01)

Patent

CA 2573810

A suspension formulation for therapeutic use includes a non-aqueous, single- phase vehicle exhibiting viscous fluid characteristics and a particle formulation comprising an erythropoietin receptor agonist dispersed in the vehicle.

La présente invention concerne une préparation de suspension destinée à une utilisation thérapeutique qui comprend un excipient monophase non aqueux présentant des caractéristiques de fluide visqueux et une préparation de particules comprenant un agoniste de récepteurs d'érythropoiétine dispersé dans cet excipient.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Stable suspension formulations of erythropoietin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable suspension formulations of erythropoietin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable suspension formulations of erythropoietin receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1635941

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.